KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Payables (2016 - 2026)

Medtronic's Payables history spans 13 years, with the latest figure at $2.6 billion for Q1 2026.

  • On a quarterly basis, Payables rose 12.38% to $2.6 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $2.6 billion, a 12.38% increase, with the full-year FY2025 number at $2.4 billion, up 1.62% from a year prior.
  • Payables hit $2.6 billion in Q1 2026 for Medtronic, roughly flat from $2.6 billion in the prior quarter.
  • Over the last five years, Payables for MDT hit a ceiling of $2.7 billion in Q2 2023 and a floor of $2.0 billion in Q1 2022.
  • Historically, Payables has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2025.
  • Biggest five-year swings in Payables: increased 16.96% in 2023 and later fell 9.82% in 2024.
  • Tracing MDT's Payables over 5 years: stood at $2.2 billion in 2022, then decreased by 1.09% to $2.2 billion in 2023, then increased by 9.29% to $2.4 billion in 2024, then grew by 8.63% to $2.6 billion in 2025, then decreased by 0.46% to $2.6 billion in 2026.
  • Business Quant data shows Payables for MDT at $2.6 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.6 billion in Q3 2025.